Emma Reeve - 15 Jun 2023 Form 4 Insider Report for Aadi Bioscience, Inc. (AADI)

Role: Director
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol: AADI
Transactions as of: 15 Jun 2023
Transactions value $: $0
Form type: 4
Filing time: 20 Jun 2023, 20:19:58 UTC
Previous filing: 05 Jun 2023
Next filing: 16 Feb 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AADI	Stock Option (right to buy)	Award	$0	+28,255		$0	28,255	15 Jun 2023	Common Stock	28,255	$8.2	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

Content

Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.